Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 290NIH 37INDUSTRY 37NETWORK 5OTHER_GOV 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 13Lymphoid 10Plasma cell 3

Conditions

Multiple Myeloma 39Neoplasms, Plasma Cell 8Lymphoma 8Hematologic Neoplasms 5Recurrence 3Leukemia 3Lymphoma, B-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoglobulin Light-chain Amyloidosis 2Disease Progression 2Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumococcal 1Pneumococcal Infections 1Peripheral Nervous System Diseases 1Neoplasms 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Mesothelioma, Malignant 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Plasma Cell 1Hodgkin Disease 1Heart Neoplasms 1Fractures, Spontaneous 1Febrile Neutropenia 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

fludarabine phosphate 1fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Leukemia × Plasma cell × Clear all
NCT06409767 2025-09-24

ALHERT

University Hospital, Angers

Phase NA Recruiting
2,224 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

NCT06262789 2024-02-16

RAT-HEMATO

University Hospital, Angers

Phase NA Not yet recruiting
264 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

NCT05528887 2022-09-06

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

The Affiliated People's Hospital of Ningbo University

Phase 1 Recruiting
10 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡